Tinos Therapeutics, Inc.

New Filing
CIK: 0002088485·Biotechnology·DELAWARE·Filed: Sep 26, 2025
Total Offering

$1,500,000

Amount Sold

$1,000,000

Investors

1

First Sale

Sep 4, 2025

Offering Details

Type
Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
Nikolaos Tapinos
Related Person
David Karambizi
Related Person
Anastasios Polimenakos
Related Person

Company

Tinos Therapeutics, Inc.

34 BOYCE AVENUE

BARRINGTON, RI, 02806

570-939-7415

SEC Filing

0002088485-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Tinos Therapeutics, Inc. Form D Filing — $1,500,000 | FilingFlow